Announced details
No serious adverse events were observed regarding the safety of VL, and the findings suggested that VL irradiation may cause changes in the menstrual cycle. Specific analysis figures are Not disclosed.
The project was selected for grant funding by the Tokyo Metropolitan Small and Medium Enterprise Promotion Corporation in March 2024. Toranomon Women's Clinic is the institution to which the study's principal investigator belongs. Capital, personnel and other business relationships are Not disclosed.
The Tokyo Metropolitan Small and Medium Enterprise Promotion Corporation provided the grant. Toranomon Women's Clinic is the institution to which the study's principal investigator belongs. Other information, including location, representative, capital and year of establishment, is Not disclosed.
Clinical study plan number: jRCTs032240394. Expiry date: Not disclosed.
The company plans to promote the expansion of future new businesses, next-generation business development and out-licensing to partner companies. The specific financial impact is Not disclosed.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | TLG-021, Device for improving irregular menstruation through violet light (VL) irradiation |
| Counterparty | Tokyo Metropolitan Small and Medium Enterprise Support Center, Medical Corporation Yukari-kai, Toranomon Women's Clinic |
| Counterparty overview | The Tokyo Metropolitan Small and Medium Enterprise Promotion Corporation provided the grant. Toranomon Women's Clinic is the institution to which the study's principal investigator belongs. Other information, including location, representative, capital and year of establishment, is Not disclosed. |
| Relationship with the Company | The project was selected for grant funding by the Tokyo Metropolitan Small and Medium Enterprise Promotion Corporation in March 2024. Toranomon Women's Clinic is the institution to which the study's principal investigator belongs. Capital, personnel and other business relationships are Not disclosed. |
| Applicable area | Femtech, Irregular menstruation |
| Registration number and expiry date | Clinical study plan number: jRCTs032240394. Expiry date: Not disclosed. |
| Quantitative Effects | No serious adverse events were observed regarding the safety of VL, and the findings suggested that VL irradiation may cause changes in the menstrual cycle. Specific analysis figures are Not disclosed. |
| Impact on Business Performance | The company plans to promote the expansion of future new businesses, next-generation business development and out-licensing to partner companies. The specific financial impact is Not disclosed. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The study was conducted as a grant-funded project of the Tokyo Metropolitan Small and Medium Enterprise Promotion Corporation to assess the trends in the safety and efficacy in humans of a device designed to improve irregular menstruation through VL irradiation. Detailed analysis results will not be disclosed until publication in an academic paper in order to ensure academic objectivity and reliability.